Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Surgery Partners (SGRY) Restructuring Costs: 2014-2025

Historic Restructuring Costs for Surgery Partners (SGRY) over the last 12 years, with Q3 2025 value amounting to $12.6 million.

  • Surgery Partners' Restructuring Costs fell 5714.29% to $12.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $73.5 million, marking a year-over-year decrease of 1393.44%. This contributed to the annual value of $100.1 million for FY2024, which is 6223.66% up from last year.
  • Latest data reveals that Surgery Partners reported Restructuring Costs of $12.6 million as of Q3 2025, which was down 5714.29% from $18.1 million recorded in Q2 2025.
  • Surgery Partners' 5-year Restructuring Costs high stood at $34.0 million for Q4 2024, and its period low was $5.3 million during Q1 2021.
  • Over the past 5 years, Surgery Partners' median Restructuring Costs value was $12.8 million (recorded in 2023), while the average stood at $16.0 million.
  • Per our database at Business Quant, Surgery Partners' Restructuring Costs skyrocketed by 12968.75% in 2024 and then tumbled by 5714.29% in 2025.
  • Quarter analysis of 5 years shows Surgery Partners' Restructuring Costs stood at $15.1 million in 2021, then surged by 30.46% to $19.7 million in 2022, then grew by 23.86% to $24.4 million in 2023, then surged by 39.34% to $34.0 million in 2024, then plummeted by 62.94% to $12.6 million in 2025.
  • Its last three reported values are $12.6 million in Q3 2025, $18.1 million for Q2 2025, and $24.7 million during Q1 2025.